Summary.-Lymphocytes from 13 chronic myeloid leukaemia (CML) patients in remission were tested for their ability to differentiate in vitro into a cell population cytotoxic to autochthonous target leukaemic cells. CML remission lymphocytes were cultured in vitro with autochthonous leukaemic cells and allogeneic normal lymphocytes from an unrelated donor, singly or in combination. The cytotoxic lymphocytes obtained after 7 days of culture were tested for their ability to kill autochthonous leukaemic cells in a 3h 5lCr-release assay. It was found that with the allogeneic stimulus alone, cytotoxicity was generated in 5/13 cases, whilst stimulation of lymphocytes with autochthonous leukaemic cells alone induced cytotoxicity in 7/13 cases. In contrast, anti-leukaemic cytotoxicity was shown in 12/13 cases when responder lymphocytes were stimulated with both autochthonous leukaemic and unrelated allogeneic normal lymphocytes.
LEUKAEMIA-ASSOCIATED immune reactivity in leukaemic patients has been shown and confirmed by several workers using in vitro humoral and cell-mediated immunological parameters (Powles et al., 1971; Leventhal et al., 1972; Harris, 1973; Durantez et al., 1]975; Garrett et al., 1977) . Among the in vitro parameters, lymphocyte-mediated cytotoxicity has often been used for the detection of leukaemiaassociated antigens on leukaemic cells (Leventhal et al., 1972; Rosenberg et al., 1972; McCoy et al., 1974) . It is, however, difficult to ascertain that the in vitro demonstration of target-cell lysis is a function of sensitized T cells. Human leukaemic blasts are possibly unable to induce cytotoxic responses in autologous remission lymphocytes (Zarling et al., 1976; Lee & Oliver, 1978) . It was felt that if the stimulator cells did not differ from the responders with respect to LD antigens, proliferative and cytotoxic responses would not be easily generated (Zarling et al., 1976; Zarling & Bach, 1979) . Sondel et al. (1976) incubated lymphocytes of HLA-identical siblings of patients with acute leukaemia with allogeneic lymphocytes and patients' blasts and demonstrated specific cytotoxicity to leukaemic blasts in 3/4 cases. Zarling et al. (1976) also showed that addition of helper stimulus enhances anti-leukaemic cell-mediated cytotoxicity in acute-leukaemic patients. Lee & Oliver (1978) extended this work further to demonstrate in vitro generation of cytotoxicity with third-party allogeneic stimulus in 11/14 AML patients. Their experiments confirmed that the cytotoxicity was mediated by T lymphocytes.
Our previous studies on chronic myeloid leukaemia (CML) have shown that CML patients in remission demonstrated cellular sensitization to CML-associated antigens, as tested by in vitro lymphocyte blastogenesis and leucocyte migration inhibition assays (Gangal et at., 1976; Gothoskar et al., 1976; Damle et al., 1979) . CML remission lymphocytes also showed reactivity to other myeloid or lymphoid leukaemic blast antigens . The present investigations were undertaken to find out whether lymphocytes from CML patients in remission are able to differentiate in vitro so as to be cytotoxic to autochthonous target leukaemic cells.
MATERIALS AND METHODS
A total of 13 untreated CML patients were used for this study. The peripheral-blood leucocyte count of these CML patients varied from 15 to 20 x 104 cells/mm3, the M/E ratio being between 10 and 30 before treatment. The leukaemic cells were cryopreserved at this stage in Dulbecco's medium supplemented with 10% foetal calf serum (FCS, Difco) and 10% dimethyl sulphoxide (DMSO) at a concentration of 1-2x 106 cells/ml in liquid N2. The cryopreserved cells were thawed in two lots, one for in vitro sensitization, the second being thawed after 7 days and used for labelling with 51chromium. The cells were rapidly thawed and slowly suspended and washed in the medium (Dulbecco's medium +10% FCS + 4 lnM/ml Lglutamine). The viability of thawed cells was > 80% in all cases.
In vitro sensitization.-The patients attained clinical and haematological remission after busulphan treatment. When they were in complete remission and off the therapy for 1-2 weeks, their peripheral-blood lymphocytes were used for the experiments.
Lymphocytes were separated using FicollHypaque density gradient and washed x 3 in 0.85% saline. The responder cells were finally suspended in culture medium (Dulbecco's medium +10% FCS + 4 mM glutamine + 5 x 10-5M 2-ME and 100 u/ml of penicillin and 50 ,ug/ml streptomycin) at a concentration of 106 cells/ml. Peripheral-blood lymphocyte suspensions from normal healthy unrelated donors were prepared in a similar way. Autologous thawed leukaemic cells and allogeneic normal lymphocytes were treated with mitomycin-C (VMC, 25 0-5 ml distilled water to determine the maximum release (100%) of radioactive chromium. After 3 h, 0 3 ml of medium was added to each tube, the cells were resuspended and tubes were centrifuged. Two 0 1ml lots of supernate from each culture was used for counting the release of 51Cr using a Biogamma Counter (Beckmann). allogeneic stimulus alone induced remission lymphocytes to express cytotoxicity to autochthonous target leukaemic cells in 5/13 cases, when compared with the cytotoxicity of lymphocytes incubated in culture medium alone, whilst stimulation of lymphocytes with autochthonous leukaemic cells alone induced cytotoxic responses in 7/13 cases. It was interesting to note that in 12/13 cases highly significant cytotoxic responses were obtained when leukaemic cells were used as stimulators along with the third-party allogeneic lymphocyte stimulus. The cytotoxicity in the 3-cell assay was higher than when by stimulating the lymphocytes with autochthonous target cells alone.
In Table II well as 3-cell culture, seemed to induce nonspecific cytotoxicity to mouse L1210 cells. However, the specific leukaemic target cell lysis in these experiments was higher than other targets.
Lymphocytes stimulated in vitro were tested on target autochthonous marrow cells in one case (AJ 13455) . It is interesting to note that lymphocytes of this patient, when stimulated with autologous leukaemic cells and allogeneic lymphocytes, showed significant cytotoxicity to autologous marrow cells.
DISCUSSION
In the present series of experiments it has been shown that CML remission lymphocytes can differentiate in vitro into a cell population highly cytotoxic to autochthonous leukaemic cells. In our experiments, in 5/13 cases cytotoxicity to autologous target leukaemic cells was displayed by responders stimulated in oneway MLC. Addition of LD stimulus by way of MLC may have caused proliferation and differentiation of cells capable of recognizing target-cell antigens.
Recently, have shown that normal T lymphocytes, sensitized in vitro against a pool of allogeneic lymphocytes, lyse autologous EBV-transformed lymphoblastoid cell lines, but not autologous lymphocytes or mitogeninduced blasts. Similarly, they have also demonstrated that peripheral-blood lymphocytes of 2 hairy-cell leukaemic patients, stimulated in vitro by a pool of allogeneic lymphocytes from 20 normal donors, kill autologous leukaemia target cells . In both these reports, however, it was stressed that lymphocytes from a single allogeneic individual are marginally capable of stimulating T cells to develop into cytotoxic lymphocytes (CTL) In the group of CML patients investigated by us, a fair number of lymphocytes capable of recognizing target-cell antigens already existed in circulation, since in MLTC-stimulated cultures 8/13 patients responded by displaying specific targetcell lysis. Zarling et al. (1976) have shown that when leukaemic blasts are used as stimulators, cytotoxicity was not always demonstrable. Lee & Oliver (1978) have shown that myeloid blasts are poor stimulators even in allogeneic stimulation. The CML leukaemic cell population consists of cells in different stages of maturation, and may express antigens which can be recognized by sensitized lymphocytes. Addition of third-party stimulus has evidently increased the cytotoxicity of CML remission lymphocytes to target leukaemic cells.
In the present investigations, besides autochthonous leukaemic target-cell lysis (shown by 12/13 patients) 1/5 patients showed cytotoxicity to PHA-transformed normal lymphoblasts, and 1/4 patients showed killing of LI 210 cells. We have not included stimulator allogeneic normal cells as targets in this study . Zarling et al. (1976 and Lee & Oliver (1978) have shown the lysis of allogeneic stimulator targets by the responders sensitized in vitro in a 3-cell assay.
It was interesting to note that lymphocytes of one patient, sensitized in vitro in a 3-cell assay, could kill target autochthon- (Zarling & Bach, 1979; Wagner, 1978) , helper factor produced by mitogen-activated lymphocytes for maintenance of cytotoxic cells in vitro (Gills & Smith, 1977) or addition of interferon in the stimulating system (Zarling & Bach, 1979) . Using animal models, it has also been possible to prevent tumour growth by mixing tumour cells with CTL generated in vitro (Glaser, 1979) . Recent evidence suggest that it is possible to maintain specific cytotoxic T cells in vitro by repetitive MLC stimulus and mitogeninduced growth factor for 4 months (Gills & Smith, 1977; Zarling & Bach, 1979) . The system thus has great potential and applicability in human situations. The present work suggests that in CML it is possible to generate a highly cytotoxic lymphocyte population by using an in vitro 3-cell system. Attempts will now be made to maintain the proliferation of CTL specifically reactive to target cells using exogenous growth factors supplied by conditioned medium.
